A comparative-effectiveness analysis applying a 3 way propensity matching to real-world data from MSBase Registry in preparation for a cost effectiveness model: patients switching within firstline agents or to natalizumab or fingolimod in active RRMS

Spelman T., Havrdova E., Horakova D., Trojano M., Lugaresi A., Izquierdo G., ...More

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 25 - 28 October 2017, vol.23, pp.395-397 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 23
  • City: Paris
  • Country: France
  • Page Numbers: pp.395-397
  • Karadeniz Technical University Affiliated: Yes